{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T18:45:49Z","timestamp":1764873949054,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Wilson disease is an autosomal recessive disease of liver copper metabolism with predominant hepatic and neurological manifestations. Long-term data on the clinical follow-up and treatment efficacy are limited due to the low frequency of the disease. We evaluated a large cohort of Wilson disease patients from Northern Portugal during a 20-year follow-up period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Twenty-four patients, diagnosed from 1975 to 2020 in a tertiary care center in Portugal, were retrospectively evaluated according to their clinical presentation, therapies and outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Most of the patients were males (54%), with a median age at diagnosis of 19\u00a0years old (interquartile range 15\u201325). The main manifestations of Wilson disease were hepatic (71%) and neurological (25%). Family history was positive in 5 (21%) patients. Four patients (17%) presented with acute liver failure and fifteen (63%) individuals had cirrhosis at diagnosis. Penicillamine therapy was used by 11 (46%) patients, while trientine and zinc were given to 8 (33%) and 1 (4%) patient, respectively. Ten (42%) individuals underwent liver transplantation. The majority of patients (83%) had stable disease or improved outcomes during follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This is the largest cohort of adult patients with Wilson disease reported in Northern Portugal. We show that Wilson disease has favorable outcomes with long overall survival, assuming adherence to therapy and lack of other insults to their liver.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02245-5","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T13:03:20Z","timestamp":1645621400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Wilson disease in Northern Portugal: a long-term follow-up study"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7801-466X","authenticated-orcid":false,"given":"Isabel","family":"Garrido","sequence":"first","affiliation":[]},{"given":"Margarida","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Rodrigo","family":"Liberal","sequence":"additional","affiliation":[]},{"given":"H\u00e9lder","family":"Cardoso","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Guilherme","family":"Macedo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"issue":"1","key":"2245_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41572-018-0018-3","volume":"4","author":"A Cz\u0142onkowska","year":"2018","unstructured":"Cz\u0142onkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, et al. Wilson disease. Nat Rev Dis Primers. 2018;4(1):21.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"2245_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/lt.25714","volume":"26","author":"A Ferrarese","year":"2020","unstructured":"Ferrarese A, Morelli MC, Carrai P, Milana M, Angelico M, Perricone G, et al. Outcomes of liver transplant for adults with Wilson\u2019s disease. Liver Transpl. 2020;26(4):507\u201316.","journal-title":"Liver Transpl"},{"issue":"15","key":"2245_CR3","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1002\/mds.21693","volume":"22","author":"JM Walshe","year":"2007","unstructured":"Walshe JM. Cause of death in Wilson disease. Mov Disord. 2007;22(15):2216\u201320.","journal-title":"Mov Disord"},{"issue":"9","key":"2245_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.disamonth.2014.07.004","volume":"60","author":"D Shah","year":"2014","unstructured":"Shah D. Wilson\u2019s disease: hepatic manifestations. Dis Mon. 2014;60(9):465\u201374.","journal-title":"Dis Mon"},{"issue":"29","key":"2245_CR5","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.4254\/wjh.v7.i29.2859","volume":"7","author":"KI Rodriguez-Castro","year":"2015","unstructured":"Rodriguez-Castro KI, Hevia-Urrutia FJ, Sturniolo GC. Wilson\u2019s disease: a review of what we have learned. World J Hepatol. 2015;7(29):2859\u201370.","journal-title":"World J Hepatol"},{"issue":"11","key":"2245_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1177\/1756283X17731520","volume":"10","author":"M Kathawala","year":"2017","unstructured":"Kathawala M, Hirschfield GM. Insights into the management of Wilson\u2019s disease. Therap Adv Gastroenterol. 2017;10(11):889\u2013905.","journal-title":"Therap Adv Gastroenterol"},{"issue":"2","key":"2245_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/hep.30911","volume":"71","author":"TD Sandahl","year":"2020","unstructured":"Sandahl TD, Laursen TL, Munk DE, Vilstrup H, Weiss KH, Ott P. The prevalence of Wilson\u2019s disease: an update. Hepatology. 2020;71(2):722\u201332.","journal-title":"Hepatology"},{"issue":"17","key":"2245_CR8","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.21037\/atm-21-2264","volume":"9","author":"SM Schroeder","year":"2021","unstructured":"Schroeder SM, Matsukuma KE, Medici V. Wilson disease and the differential diagnosis of its hepatic manifestations: a narrative review of clinical, laboratory, and liver histological features. Ann Transl Med. 2021;9(17):1394.","journal-title":"Ann Transl Med"},{"issue":"3","key":"2245_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jhep.2011.11.007","volume":"56","author":"EASL Clinical Practice Guidelines","year":"2012","unstructured":"EASL Clinical Practice Guidelines. Wilson\u2019s disease. J Hepatol. 2012;56(3):671\u201385.","journal-title":"J Hepatol"},{"key":"2245_CR10","doi-asserted-by":"crossref","unstructured":"EASL Clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406\u201360.","DOI":"10.1016\/j.jhep.2018.03.024"},{"issue":"8","key":"2245_CR11","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1016\/S0041-1345(00)01834-0","volume":"32","author":"G Macedo","year":"2000","unstructured":"Macedo G, Maia JC, Gomes A, Amil J, Fernandes N, Carneiro F, et al. Wilson\u2019s disease: challenging diagnosis, management, and liver transplantation timing. Transplant Proc. 2000;32(8):2668.","journal-title":"Transplant Proc"},{"issue":"21","key":"2245_CR12","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.3390\/jcm10215097","volume":"10","author":"B Kasztelan-Szczerbinska","year":"2021","unstructured":"Kasztelan-Szczerbinska B, Cichoz-Lach H. Wilson\u2019s disease: an update on the diagnostic workup and management. J Clin Med. 2021;10(21):5097.","journal-title":"J Clin Med"},{"issue":"Suppl 2","key":"2245_CR13","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.21037\/atm.2019.02.37","volume":"7","author":"A Cz\u0142onkowska","year":"2019","unstructured":"Cz\u0142onkowska A, Dzie\u017cyc-Jaworska K, K\u0142ysz B, Barbara RO, Litwin T. Difficulties in diagnosis and treatment of Wilson disease-a case series of five patients. Ann Transl Med. 2019;7(Suppl 2):S73.","journal-title":"Ann Transl Med"},{"issue":"11","key":"2245_CR14","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.2169\/internalmedicine.43.1012","volume":"43","author":"M Harada","year":"2004","unstructured":"Harada M. Wilson disease and hepatocellular carcinoma. Intern Med. 2004;43(11):1012\u20133.","journal-title":"Intern Med"},{"issue":"3","key":"2245_CR15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/jgh.12716","volume":"30","author":"S van Meer","year":"2015","unstructured":"van Meer S, de Man RA, van den Berg AP, Houwen RH, Linn FH, van Oijen MG, et al. No increased risk of hepatocellular carcinoma in cirrhosis due to Wilson disease during long-term follow-up. J Gastroenterol Hepatol. 2015;30(3):535\u20139.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"2245_CR16","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/hep.29490","volume":"67","author":"J Pfeiffenberger","year":"2018","unstructured":"Pfeiffenberger J, Beinhardt S, Gotthardt DN, Haag N, Freissmuth C, Reuner U, et al. Pregnancy in Wilson\u2019s disease: management and outcome. Hepatology. 2018;67(4):1261\u20139.","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"2245_CR17","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.21037\/atm.2019.04.40","volume":"7","author":"U Reuner","year":"2019","unstructured":"Reuner U, Dinger J. Pregnancy and Wilson disease: management and outcome of mother and newborns-experiences of a perinatal centre. Ann Transl Med. 2019;7(Suppl 2):S56.","journal-title":"Ann Transl Med"},{"issue":"3","key":"2245_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.clinre.2015.09.007","volume":"40","author":"M Schaefer","year":"2016","unstructured":"Schaefer M, Gotthardt DN, Ganion N, Wohnsland S, Seessle J, Stremmel W, et al. Wilson disease: health-related quality of life and risk for depression. Clin Res Hepatol Gastroenterol. 2016;40(3):349\u201356.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"5","key":"2245_CR19","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jaclp.2021.04.004","volume":"62","author":"MA Camarata","year":"2021","unstructured":"Camarata MA, Ala A, Coskun AK, Deng Y, Gonzalez-Peralta RP, Maciejewski KR, et al. The effect of mental health, neurological disease, and liver disease on quality of life in patients with Wilson disease. J Acad Consult Liaison Psychiatry. 2021;62(5):528\u201337.","journal-title":"J Acad Consult Liaison Psychiatry"},{"issue":"2","key":"2245_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.36469\/jheor.2021.29987","volume":"8","author":"C Balijepalli","year":"2021","unstructured":"Balijepalli C, Yan K, Gullapalli L, Barakat S, Chevrou-Severac H, Druyts E. Quality of life in Wilson\u2019s disease: a systematic literature review. J Health Econ Outcomes Res. 2021;8(2):105\u201313.","journal-title":"J Health Econ Outcomes Res"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02245-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02245-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02245-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T13:17:21Z","timestamp":1645622241000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02245-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2245"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02245-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2022,2,23]]},"assertion":[{"value":"16 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}